Nat Krishnamurti - HUDSON TECHNOLOGY Chief Financial Officer, Vice President
| HT4 Stock | EUR 5.30 0.05 0.93% |
President
Mr. Nat Krishnamurti, CPA, is a Chief Financial Officer, Vice President of the Company. Mr. Krishnamurti was the Chief Financial Officer and Interim Chief Financial Officer of Interpace Diagnostics Group, Inc. during 2016 after serving as Vice President, Corporationrationrate Controller and Chief Accounting Officer from August 2015 to February 2016. Prior to joining Interpace, Mr. Krishnamurti served as chief financial officer of Applied Minerals, Inc., a publicly traded company, from May 2012 to August 2015. Prior to Applied Minerals, from May 2000 to September 2011, Mr. Krishnamurti served as Chief Accounting Officer for inVentiv Health, a global provider of clinical, communications and commercial services which was publicly traded until August 2010. While at inVentiv Health, he also held various finance positions of increasing responsibility, including Manager, Director, and VP of Finance. Prior to inVentiv Health, Mr. Krishnamurti worked in public accounting firms, including PricewaterhouseCoopers LLP since 2016.
| Age | 47 |
| Tenure | 8 years |
| Professional Marks | MBA |
HUDSON TECHNOLOGY Leadership Team
Elected by the shareholders, the HUDSON TECHNOLOGY's board of directors comprises two types of representatives: HUDSON TECHNOLOGY inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUDSON. The board's role is to monitor HUDSON TECHNOLOGY's management team and ensure that shareholders' interests are well served. HUDSON TECHNOLOGY's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUDSON TECHNOLOGY's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Otto Morch, Independent Director | ||
| Ryan Maupin, Chief Restructuring Officer | ||
| Eric Prouty, Independent Director | ||
| Jill Frizzley, Director | ||
| Brian Coleman, Chairman of the Board, President, Chief Executive Officer | ||
| Stephen Mandracchia, Vice President - Legal and Regulatory, Secretary | ||
| Richard Parrillo, Independent Director | ||
| Dominic Monetta, Independent Director | ||
| Richard Caruso, Director | ||
| Kenneth Gaglione, Vice President - Operations | ||
| Nat Krishnamurti, Chief Financial Officer, Vice President | ||
| Vincent Abbatecola, Independent Director |
HUDSON Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HUDSON TECHNOLOGY a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 516.75 M | |||
| Price To Book | 3.01 X | |||
| Price To Sales | 1.70 X | |||
| Revenue | 192.75 M | |||
| EBITDA | 50.95 M | |||
| Net Income | 32.26 M | |||
| Total Debt | 73.14 M | |||
| Cash Flow From Operations | (1.23 M) | |||
| Price To Earnings To Growth | 0.25 X | |||
| Number Of Employees | 15 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in HUDSON Stock
HUDSON TECHNOLOGY financial ratios help investors to determine whether HUDSON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HUDSON with respect to the benefits of owning HUDSON TECHNOLOGY security.